Editor(s):
(1) Dr. Zhiheng Zhou, Thyroid Cancer Research Laboratory, Massachusetts General Hospital, Harvard Medical School, USA.
Reviewers:
(1) Saibijaya Rijal, Manmohan Technical University, Nepal.
(2) Sunčica Ivanović, College of Applied Health Sciences, Serbia.
(3) Behnam Talebi, Islamic Azad University, Iran.
Additional Reviewers:
Additional Reviewers: (Comments received after deadline)
(1) V.E.Ida Christi, PSG College of Pharmacy, India.
(2) Derbissalina Gulmira, Astana Medical University, Kazakhstan.
(3) Ndoe Guiaro Marcellin, Institute of Medical Research and Medicinal Plants Studies, Cameroon.
(4) Peder Hjorth, Lund Univesity, Sweden.
Open Peer Review Policy: Click Here
Specific Comment:
Average Peer review marks at initial stage: 8.67/10
Average Peer review marks at publication stage: 9/10
Peer Review History:
Stage 1 | Original Manuscript | File 1 | NA
Stage 2 | Peer review report_1 (Saibijaya Rijal, Nepal) | File 1 | File 2
Stage 2 | Peer review report_2 (Sunčica Ivanović, Serbia) | File 1 | NA
Stage 2 | Peer review report_3 (Behnam Talebi, Iran) | File 1 | NA
Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2
Stage 3 | Comment_Editor_1_v1 | File 1 | NA